AurorA Science is a biotech investment company integrating an innovative financial and industrial
approach in the research and development challenge. The company is focused on independent
and entrepreneurial biotech start-ups with high therapeutic potential.
AurorA Science stems from the partnership between a management team, AurorA-TT, and two strategic industrial partners,
Rottapharm Biotech and Italfarmaco. AurorA-TT brings in operational excellence and expertise in bio-pharma, venture, translational medicine and technology transfer
Rottapharm Biotech and Italfarmaco provide skills and know how though in-house R&D facilities, expertise in drug development and partnering with bio-pharma companies.
Investment size ranges between €1 and 5M per deal to support IND-enabling studies and early clinical development.